# Modified Natural Cycle Offers a Chance of Pregnancy in Patients With Poor Response and High Basal FSH

> **NCT00417157** · — · COMPLETED · sponsor: **Eugonia** · enrollment: 135 (actual)

## Conditions studied

- Infertility
- Premature Ovarian Failure

## Interventions

- **DRUG:** recombinant FSH (Puregon, Organon, The Netherlands)
- **DRUG:** GnRH antag: Ganirelix (Orgalutran, Organon, The Netherlands)
- **DRUG:** hCG (Pregnyl, Organon, The Netherlands)

## Key facts

- **NCT ID:** NCT00417157
- **Lead sponsor:** Eugonia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 135 (ACTUAL)
- **Last updated:** 2013-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00417157

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00417157, "Modified Natural Cycle Offers a Chance of Pregnancy in Patients With Poor Response and High Basal FSH". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00417157. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*